The Capital Group Companies, Inc. reduced its holding of INNOVENT BIO (01801) by approximately 3,327,400 shares at a price of around HK$31.55 per share.
On January 20th, The Capital Group Companies, Inc. reduced its holdings in Sino Biopharmaceutical (01801) by 3,327,405 shares, priced at 31.5469 Hong Kong dollars per share, for a total amount of approximately 105 million Hong Kong dollars.
According to the latest data from the Hong Kong Stock Exchange, on January 20, The Capital Group Companies, Inc. reduced its holdings of INNOVENT BIO (01801) by 3,327,405 shares, at a price of 31.5469 Hong Kong dollars per share, with a total amount of approximately 105 million Hong Kong dollars. After the reduction, the latest number of shares held is approximately 96,778,400 shares, with a shareholding proportion of 5.91%.
Related Articles

HAITONG UT(01905): "24 Hengxin G1" will pay interest on January 15th.

New stock news | Sany sent documents to Hong Kong Stock Exchange

LINGBAO GOLD (03330) announces profit joy, with an estimated net profit of approximately 1.503 billion to 1.573 billion yuan in 2025, an increase of approximately 115% to 125% year-on-year.
HAITONG UT(01905): "24 Hengxin G1" will pay interest on January 15th.

New stock news | Sany sent documents to Hong Kong Stock Exchange

LINGBAO GOLD (03330) announces profit joy, with an estimated net profit of approximately 1.503 billion to 1.573 billion yuan in 2025, an increase of approximately 115% to 125% year-on-year.

RECOMMEND

Bank Of America Sees Three Drivers Supporting Chinese Consumer Stocks: Low Base, Deep Undervaluation, And Convertible‑Like Defensive Traits
07/01/2026

Cross‑Border E‑Commerce In 2025: Tariffs, Trade Wars, And Shifting Away From The United States
07/01/2026

Asian Stock Markets Record The Strongest Annual Start Ever As Shanghai Composite Hits Multi‑Year High And Sets Longest Winning Streak; Japan And Korea Rally
07/01/2026


